1960
DOI: 10.1038/187784a0
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism of the Physiological Action of Rotenone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

1963
1963
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 2 publications
0
8
0
Order By: Relevance
“…The inhibition of mitochondrial complex I (NADH:ubiquinone oxidoreductase) was established as essential to their mechanism of action and selective toxicity . This finding further highlights the therapeutic potential of 1 and 2 and is consistent with their being canonical ubiquinone-binding site inhibitors of complex I. Complex I is a major entry point for electrons into the mitochondrial respiratory chain and an integral contributor to oxidative phosphorylation (OxPhos), which is a target for other potential anticancer compounds, such as metformin , and IACS-010759 from the MD Anderson Cancer Center. It oxidizes the NADH produced by the citric acid cycle and other metabolic pathways, transfers the electrons to ubiquinone to sustain the reduction of molecular oxygen through complexes III and IV, and transports protons across the mitochondrial inner membrane to maintain the proton motive force that drives ATP synthesis and metabolite transport .…”
mentioning
confidence: 69%
“…The inhibition of mitochondrial complex I (NADH:ubiquinone oxidoreductase) was established as essential to their mechanism of action and selective toxicity . This finding further highlights the therapeutic potential of 1 and 2 and is consistent with their being canonical ubiquinone-binding site inhibitors of complex I. Complex I is a major entry point for electrons into the mitochondrial respiratory chain and an integral contributor to oxidative phosphorylation (OxPhos), which is a target for other potential anticancer compounds, such as metformin , and IACS-010759 from the MD Anderson Cancer Center. It oxidizes the NADH produced by the citric acid cycle and other metabolic pathways, transfers the electrons to ubiquinone to sustain the reduction of molecular oxygen through complexes III and IV, and transports protons across the mitochondrial inner membrane to maintain the proton motive force that drives ATP synthesis and metabolite transport .…”
mentioning
confidence: 69%
“…Along with the substitution of atmospheric conditions, U2OS cells were placed in drug-free culture medium or in medium supplemented with STS (a broad-spectrum kinase inhibitor that interrupts most—if not all—trophic signaling cascades), 30 mitoxantrone (a DNA-damaging anthracycline), 31 rotenone (an inhibitor of the complex I of the mitochondrial respiratory chain), 32 antimycin A (an inhibitor of the complex III of the mitochondrial respiratory chain), 33 or menadione (a redox-cycling agent that stimulates the overproduction of reactive oxygen species), 34 for 6 or 16 h. At the end of the experiment, culture plates were fixed and processed by a robotized fluorescence microscopy-based imaging platform for the automated quantification of residual cell number.…”
Section: Resultsmentioning
confidence: 99%
“…To test whether the accumulation of FlAsH/Lumio Green in mitochondria is activity-dependent, we inhibited mitochondrial respiration by a short incubation with 5 lM Rotenone (Lindahl and Oberg 1960). This treatment abolished labeling of the mitochondria by FlAsH/Lumio Green (Fig.…”
Section: Flash/lumio Green Accumulates In Active Mitochondriamentioning
confidence: 99%